Safinamid for anvendelse i kombinasjon med levodopa/DPI samt eventuelt med andre PD medisinske produkter for behandling av Parkinsons sykdom

• 收藏
• 分享

专利权人:

NEWRON PHARM SPA

发明人:

申请号：

NO2015018

公开号：

NO2015018I1

申请日:

2015.07.23

申请国别(地区):

NO

年份:

2015

代理人:

摘要：

New uses of safinamide, safinamide derivatives and MAO-B inhibitors in novel types of treatment for Parkinsons Disease are described. More specifically, the invention relates to methods for treating Parkinsons Disease through the administration of safinamide, a safinamide derivative, or a MAO-B inhibitor, in combination with other Parkinsons Disease agents or treatments, such as levodopa/PDI or dopamine agonists.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/